| __timestamp | Amneal Pharmaceuticals, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 3401685 |
| Thursday, January 1, 2015 | 136870000 | 4284228 |
| Friday, January 1, 2016 | 204747000 | 3581295 |
| Sunday, January 1, 2017 | 191938000 | 4838300 |
| Monday, January 1, 2018 | 210451000 | 24891534 |
| Tuesday, January 1, 2019 | 202287000 | 31347891 |
| Wednesday, January 1, 2020 | 190585000 | 17480747 |
| Friday, January 1, 2021 | 209563000 | 34710152 |
| Saturday, January 1, 2022 | 200046000 | 108459978 |
| Sunday, January 1, 2023 | 167778000 | 181563523 |
| Monday, January 1, 2024 | 176326321 |
Infusing magic into the data realm
In the competitive landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Amneal Pharmaceuticals, Inc. and Opthea Limited have shown contrasting trajectories in their R&D investments. From 2014 to 2023, Amneal's R&D expenses have fluctuated, peaking in 2018 with a 20% increase from 2014, before experiencing a decline by 2023. In contrast, Opthea Limited has demonstrated a remarkable upward trend, with R&D spending surging by over 5000% from 2014 to 2023. This dramatic increase underscores Opthea's aggressive push towards innovation, particularly evident in 2023 when their R&D expenses surpassed Amneal's for the first time. As we look to the future, these spending patterns may signal shifts in market leadership and innovation breakthroughs.
Comparing Innovation Spending: Incyte Corporation and Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
BioMarin Pharmaceutical Inc. vs Opthea Limited: Strategic Focus on R&D Spending
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CRISPR Therapeutics AG
Opthea Limited vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.